In sarcopenia, lifting rebuilds strength far more than muscle

Sarcopenia, the age-related loss of muscle mass and strength, undermines independence and raises the risk of falls and frailty in later life. Resistance training is the obvious countermeasure, but how much it can actually restore in people already diagnosed with sarcopenia, and which training variables matter most, has been unclear. There is also interest in whether lifting shifts the body's hormonal and inflammatory environment in this group. This analysis pooled the randomised trials to size up all three questions.

The researchers pooled 22 randomised controlled trials involving 959 older adults with sarcopenia. They examined body composition, muscle strength and blood biomarkers, expressing results as standardised effect sizes. Regression analyses identified which factors predicted outcomes, including training period, number of sets, contraction speed, training intensity and participant age. Subgroup analyses then tested which combinations of those variables produced the largest effects.

Strength responded most: resistance training had large effects on handgrip strength and knee extension strength, though the chair stand test did not improve. Muscle mass gains were real but small, and body fat percentage did not fall. Programmes of 3 or more sets at intensities above 70% of one-repetition maximum showed the strongest handgrip effects, while 3 sets over 8 to 12 weeks with slower contractions at 60 to 70% of maximum looked best for body composition. Biomarkers shifted too: insulin-like growth factor 1, interleukin-10 and follistatin rose, while interleukin-6, TNF-α and myostatin did not change.

This supports the established view that resistance training is the frontline response to sarcopenia, and adds useful detail on programming. The pattern of large strength gains alongside small mass gains echoes wider exercise science, where strength improves through the nervous system and muscle quality as well as size. The null result for pro-inflammatory markers complicates the idea that lifting broadly dampens inflammation in this group. How the gains translate into everyday function is less certain, given the chair stand test did not improve.

For older adults with diagnosed muscle loss, this is strong pooled evidence that lifting rebuilds strength substantially even when the tape measure moves less. The programming signals here, multiple sets and meaningful intensity, suggest token gentle sessions may leave results on the table. It is also a reason not to expect resistance training alone to strip body fat in this population. As ever, results in sarcopenic older adults will not map neatly onto younger trainees.